Serb Pharmaceuticals

SERB is a global specialty pharmaceutical company with a growing portfolio of medicines for rare diseases, rare emergencies, and CBRN preparedness. For over 30 years we have consistently supplied emergency medicines, medical countermeasures, and the world’s leading portfolio of antidotes. SERB began in France as Société d’Études et de Recherches Biologiques (Company for Biologic Study and Research), but today our direct commercial presence spans US, Europe, and the Middle East. Healthcare providers in over 100 countries rely on us for a broad range of essential medicines delivered via healthcare systems, first responders, emergency preparedness agencies, and non-profit organisations. Our proven ability to acquire, develop, manufacture, launch and commercialize specialist medicines allows us to meet critical medical needs with urgency. By expanding our reach through selective acquisitions and entering new markets, we’re not just supplying medicine; we’re improving the standard of care for more patients around the world. Improving patients’ quality of life and offering hope is what motivates and inspires us.